SEC Form 4 · accession 0001171843-18-005067
PALISADE BIO, INC. · PALI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cristina Csimma
Director
Period of report
Jul 2, 2018
Accepted (ET)
Jul 5, 2018 · 4:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001357459
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Purchase OptionF1 | $1.11 | Jul 2, 2018 | A | 59,660 | A | Jul 2, 2018 | Jul 2, 2028 | Common Stock | 59,660 | 59,660 | D |
Explanation of responses
- F1Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19.